About
Ambulero, Inc is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.
Team & affiliation
Founders: [object Object], [object Object], [object Object], [object Object].
Region context
Ambulero is one of 16 Biotechnology companies we track in South Florida / Miami, based in Miami — about 2% of the region's 650 startups.
South Florida centers on Miami's fintech, crypto, and Latin-America-facing startup base.
See the full South Florida / Miami ecosystem →